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Summary Despite the efforts of the international community diarrheal dis-
eases still pose a major threat to children in children less than ﬁve years of
age. Bacterial diarrhea has also emerged as a public health concern due to the
proliferation of drug resistant species in many parts of the world. There is a
paucity of population-based data about the incidence of shigellosis and Campy-
lobacter infections in Pakistan. We report country speciﬁc results for Shigella
diarrhea that were derived from a multicenter study conducted in six Asian coun-
tries. Disease surveillance was conducted over a 24 month period in urban slums
of Karachi, Pakistan, a city with a population of 59,584. Cases were detected
through passive detection in study treatment centers. Stool specimens or rectal
swabs were collected from all consenting patients. Between January 2002 and
December 2003 10,540 enteric infection cases were detected. The incidence rate
of treated diarrhea in children under 5 was 488/1000/year. In children, 5 years
and older, the diarrhea rate was 22/1000/year. 576 (7%) Campylobacter isolates
were detected. The pre-dominant Campylobacter species was C. jenuni with an
increase of 29/1000 year in children under 5 years. Shigella species were iso-
lated from 394 of 8032 children under 5 years of age. Shigella ﬂexneri was the
dominant species (10/1000/year in children under 5 years) followed by Shigella
sonnei (3.9/1000/year), Shigella boydii (2.0/1000/year) and Shigella dysenteriae
(1.3/1000/year). Shigellosis and Campylobacter infection rates peaked during the
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second year of life. The incidence rate of shigellosis increased in old age but such
a trend was not observed in Campylobacter infections. Of 394 shigellosis patients
123 (31%) presented with dysentery in contrast to only 54 (9%) of 576 patients with
Campylobacter infections (p < 0.001). Both Campylobacter infections and shigellosis
are common in community settings of Pakistan but shigellosis presented more fre-
quently with abdominal pain and dysentery than Campylobacter infections indicating
that shigellosis may be a more severe illness than Campylobacter infections. Due to
the increased and disease severity, drug resistant shigella have become a signiﬁcant
health problem; moreover it is a disease of poor and impoverished people who do not
have the access to standard water and sanitary conditions, health care services or
optimal treatment. In the face of these facts it is empirically important to develop a
low cost effective vaccine that can protect these populations for a longer duration.
dulaziz University for Health Sciences. Published by Elsevier
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The Campylobacter disease burden is also quite© 2010 King Saud Bin Ab
Ltd. All rights reserved.
ntroduction
espite efforts of the global community to control
nd prevent the diarrheal diseases, they still remain
major cause of morbidity and mortality in children
specially in impoverished areas of South East Asia
1,2] moreover the incidence of dysentery (which
s an aggravated diarrheal condition characterized
y frequent passage of stool containing blood and
ucus) has also increased. Much of the dysentery
s considered to be of bacillary origin species of
higella (S. ﬂexneri, S. sonnei, S. dysenteriae, and
. boydii) and Shigellosis has become a public health
ssue [3].
On a global level, it is estimated that about 165
illion cases of diarrhea due to Shigella occurs
nnually, 99% occur in developing countries, and
n developing countries 69% of episodes occur in
hildren under ﬁve years of age. About 1.1 mil-
ion deaths are attributed to Shigella infections in
eveloping countries, 60% of which occur in the
nder-ﬁve age group [3]. A multicenter study con-
ucted in six Asian countries illustrates incidence
ates of Shigellosis up to 13% [4]. A combination of
isease severity and antibiotic resistance is posing
real dilemma especially in young children [5,6].
he recognition of extended range beta lactamases
n Shigella strains may well jeopardize the effec-
iveness of antibiotics including third-generation
ephalosporins [7—9]. The appearance of resistance
gainst the majority of antimicrobials has added
rgency to the development of vaccines which
an protect against shigellosis while to date only
single vaccine to protect against shigellosis is
ccredited worldwide [10].
Campylobacter infection is also a common causef acute gastroenteritis both in the developed and
eveloping countries and like other bacterial infec-
ions incidence is much higher in the developing
ations due to poor water and sanitary conditions
h
B
i
gnd mishandling of food [11,12]. Based on the
tudies from Thailand and Mexico the incidence
ates are estimated to be 40,000 per 100,000 for
hildren younger than ﬁve years [11]. In develop-
ng countries, Campylobacter infections in children
ommonly occur under the age of two years and can
ometimes leads to death and other complications
12]. In several community-based surveys Campy-
obacter jejuni was the most commonly isolated
nteropathogen in diarrheal stools from children
ged less than 5 years [13].
Like shigellosis Campylobacter infections are
lso wide spread and C. jejuni is considered to be
common cause of acute bacterial gastroenteritis
lobally. The organism becomes more serious
ue to its association with serious post-infection
eurological complications. A study conducted
y Clarence et al. reveals a much increased
isk of Gullien Barre Syndrome (GBS) among
ampylobacter enteritis patients compared with
reviously reported studies [14]. Campylobacter
re widespread in both developed and developing
ountries but due to increasing incidence and
omplication much attention is required to address
he problem in developing countries [15].
Drug resistance is also an important factor while
ddressing Campylobacter infections. Addressing
hese infections in many developed countries is a
riority due to the emergence of increased levels
f macrolide resistance [16]. Further the infections
ortray the same situation of drug resistance even
n the developing countries which is evident from
he studies conducted in Thailand by Serichanta-igh in the south Asian region. Studies from
angladesh, India and Pakistan reveals that it
s one of the most frequent organisms causing
astroenteritis [18]. In Pakistan the presence of
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Campylobacter organisms are quite high in food
commodities which are usually used by the common
man [19], which in turn results in an increased inci-
dence of Campylobacter infections (12%) in all age
groups [20]. Another study conducted at Rawalpindi
reveals that C. jejuni is the most frequent cause
of childhood diarrhea and dysentery in that setting
[21].
Due to its epidemiological spread, Pakistan is a
potential site for future vaccine trial and in ground-
ing of future vaccine trial sites it is crucial to
recognize the shigellosis incidence as shigellosis is
much more notorious than the other enteric organ-
isms. Our study is the foremost community based
study to estimate the factual incidence of shigel-
losis on a population level. Earlier hospital based
studies do not provide a denominator essential for
incidence estimates [22—29]. Not only is it signif-
icant to appreciate the shigellosis incidence in a
study area it is evenly imperative to understand
the distribution of Shigella serogroups, types, and
subtypes because the knowledge about cross pro-
tection between Shigella serotypes and subtypes
is very limited at best [30]. We have consequently
conducted shigellosis surveillance in 4 urban slums
of Karachi over a 24 months period. The unexpect-
edly high detection rates of Campylobacter species
have allowed us to evaluate and contrast the epi-
demiology as well as the clinical presentation of
shigellosis and Campylobacter infections.
Methods
This study was done as a part of the Multicenter
study for Shigella diarrhea in six Asian countries
[4] to compare shigellosis with campylobacterio-
sis in four slum communities, in Karachi, Pakistan
(Rehri Goth, Sherpao Colony, Sultanabad and Hijrat
Colony). Pashto and Hazara migrants from the
NWFP Province of Pakistan are the major population
groups in the impoverished slum areas of Sherpao
colony, Hijrat colony and Sultanabad. Rehri Goth is
a much older ﬁshing community mainly consisting of
Sindhi speaking settlers. A census was conducted in
each of the communities prior to the surveillance
that demonstrated a population of 59,584 indi-
viduals including 8381 children less than 5 years.
Karachi is a tropical area with hot summers last-
ing from April through October and more moderate
temperatures for the rest of the year, rains are
expected during the second half of each summer
but can skip one or more years.
The health care system of these slums con-
sisted of 79 private practitioners, among them 32
were the graduates from medical colleges [31].
i
h
m
s
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he quackery medical practice was common and
uacks or ‘‘village doctors’’ who have no for-
al training or degree used to prescribe allopathic
edications even antibiotics. Untrained pharmacy
hopkeepers and registered pharmacists provide
edication based on the description of the signs
nd symptoms of the patient over the counter. In
ddition, a variety of traditional healers (Hakims)
nd homoeopaths practiced in the study areas.
nce these primary health care providers have been
xhausted the residents of the study areas can seek
reatment from hospitals. A study clinic was estab-
ished in each of the 4 slums for more than a year
efore the surveillance started, these clinics were
quipped with trained doctors, medicines and rel-
vant laboratory equipment. The clinics provided
ree medical services for residents. The availabil-
ty of free healthcare in the study clinics had been
nnounced during community meetings when resi-
ents were asked to attend the study clinics in case
f diarrhea. The presence of the study clinics was
urther publicized during the census.
We estimated the burden of enteric diseases
hrough a population-based, surveillance system. A
assive case detection system was used which cap-
ured patients when they visited the study clinics.
ach household was visited weekly and the house-
old head or a representative was asked about
iarrhea cases in the preceding 7 days. If a diarrhea
ase was reported the patient was asked to come to
he study clinic. The study followed a generic pro-
ocol, which was adapted to local needs by staff
nd collaborating centers [32]. Verbal consent was
btained from each participant (parent or guardian
or children) following an explanation of the pur-
ose of the study.
Consenting patients of all age groups with diar-
hea or dysentery presenting to the study clinics
ere eligible to participate in the study. Diarrhea
as deﬁned as three or more loose bowel move-
ents during a 24-h period, dysentery as one or
ore loose bowel movements with visible blood,
nd fever as an axillary temperature of 37.5 ◦C or
igher. Diarrhea following three days or more of
ormal bowel movements was considered a new
iarrhea episode. For every patient presenting with
iarrhea, a case report form (CRF), describing
emographics and medical history & examination
as completed and two rectal/stool swabs or a
tool specimens were obtained. All the cases were
rovided with the standard treatments as outlined
n the protocols. All consenting patients with a
istory of dysentery or diarrhea for three days or
ore were eligible to participate in the study. The
tudy received approval from the Aga Khan Univer-
ity Ethics Review Committee and the Secretariat
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10540 Diarrhea Patients presented *
90 Revisits
70 Not eligible†
2339 didn’t provide a specimen
8032 patients enrolles
576 campylobacter Isolates¶
547 C. Jejuni
24 C.Coli
5 C. Larid
394 Shigella Isolates‡
242 S. Flexerni
72 S. Sonnei
42 S. Boydii
37 S. dysenteriae
340 Other Isolates§
129 V. Cholerae
56 E.Coli
98 Salmonella Spp.
57 Aeromonas Spp.
6756 No organism Isolated
*During the study period 1/1/2002 to 12/31/03
†Didn’t fulfill the inclusion criteria
‡From 22 patients more than one organism was isolated
¶From 25 patients more than one organism was isolated
§From 21 patients more than one organism was isolated
Figure 1 Case assembly. *During the study period
1/1/2002 to 12/31/03. †Did not fulﬁll the inclusion cri-
t ‡
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ommittee for Research Involving Human Subjects,
HO, Geneva, Switzerland.
To isolate the exact organism we set up a stan-
ard laboratory at every clinic. We obtained three
ectal swabs one for buffered glycerol saline (BGS),
ne for alkaline peptone water APW and one for
hosphate buffered saline PBS and along with that
e ask the patient to bring a stool sample in a con-
ainer for stool culture. All these medias were used
or the enrichment and transport of the isolates to
he Central Lab at Aga Khan University, Karachi,
akistan. The collected stool samples were also
lated immediately onto XLD-, SS-, MacConkey’s-
gar and incubated at 37 ◦C for 18—24 h before
ransport at the center. All swabs and stool samples
ere stored refrigerated and transported daily in a
ool box to the Central Laboratory at Aga Khan Uni-
ersity, Karachi following the standard protocols.
he Central Laboratory at Aga Khan University is
ne of the state of the art laboratories in the South
sian region. To ensure the robust implementation
f laboratory procedures, the doctors of the health
enters received an extensive training for all labo-
atory procedures.
On arrival specimens in BGS were plated on
acConkey’s agar and Salmonella-Shigella agar.
iochemical reactions of lactose negative colonies
ere evaluated with Triple Sugar Iron agar and
ysine Indole Motility medium isolates producing
eactions consistent with shigella were sero-
ogically conﬁrmed by slide agglutination with
ppropriate group-speciﬁc polyvalent antisera,
ollowed by type-speciﬁc monovalent antisera
Denka-Seiken, Tokyo, Japan). In cases where no
gglutination occurred with live bacteria, the test
as repeated with boiled suspensions of bacteria.
ampylobacter was identiﬁed after 48 h by colony
orphology, oxidase test, Gram staining, and motil-
ty. The organisms were identiﬁed to species level
y a positive catalase test, a negative urease test,
ailure to produce H2S, and non-fermentation in
SI, resistance to cephalotin, nitrate reaction and
ippurate hydrolysis. Although in the main study of
higella diarrhea the investigators look for Shigella
sing PCR but that was not done in Pakistan. All PCR
tudies were conducted at the USAFRIMS, Bangkok,
hailand [4].
All Case Record Forms were archived serially
n the box ﬁles and then were double entered
nto a custom-made data entry programs (FoxPro,
icrosoft, Redmond, WA, USA). The data manage-
ent programs included error as well as consistency
nd range check programs. Chi-square tests were
sed for binary data analysis. For the analysis of
on-normally distributed data, Wilcoxon rank sum
est was applied. Data were analyzed with SAS
R
D
1eria. From 22 patients more than one organism was
solated. ¶From 25 patients more than one organism was
solated. §From 21 patients more than one organism was
solated.
oftware (SAS Institute Inc., Cary, NC, USA) and
tata/SE 8 (Stata Corp., Texas, USA). A p-value less
han 0.05 (2-tailed) was considered signiﬁcant. Inci-
ence rates were calculated by using age-speciﬁc
enominators of the population residing in the
atchment area in 2001. We calculated 95% CI for
he incidence rates by the Wilson score method
33]. As the observation period was 24 months,
e assumed that each person residing in the study
rea contributed 24 months of person time to the
enominator. The number of age-speciﬁc disease
pisodes was used as numerator. For the compar-
son of clinical presentations only patients were
ncluded from whom a single organism was isolated.
atients with multiple infections (co-infections)
ere excluded.
Through out the surveillance period, the senior
evel staff did regular ongoing monitoring and eval-
ation of various process and outcome indicators.
he data management unit produced an indicator
eport on weekly basis that reﬂected the ﬂow of the
roject activities. To ensure the proper implemen-
ations of the project, regular refresher trainings
ere provided to the staff involved in the project.esults
uring the 24 month study period, which started
st January 2002 and ended on 31st December
16 S.B. Sooﬁ et al.
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lation to weather changes in Karachi, Pakistan in 2003.
serotypes were 2a (38 of 89 isolates; 16%) followed
by S. ﬂexneri 6 (37 isolates; 15%), S. ﬂexneri 1b (25
isolates; 10%), and S. ﬂexneri 2b (23 isolates; 10%).JuMay-03Apr-03Mar-03Feb-03Jan-03
Figure 2 (a and b) Seasonality of enteric infections in re
2003 10,540 enteric infection cases were detected
(Fig. 1). The incidence rate of treated diarrhea in
children under 5 years was 488/1000/year com-
pared to 22/1000/year in the older population. This
high incidence in young children is a clear evi-
dence that the enteric infections still prevail in the
younger populations.
Enteric infections (diarrhea, dysentery) and
speciﬁcally Campylobacter infections and shigel-
losis increased during the warmer months of the
year (Fig. 2a and b). There was no correlation
between changes in enteric infections rate and
rainfall in 2003.
From 8032 stool specimens 394 (5%) Shigella
species were isolated. S. ﬂexneri was the dom-
inant species (10/1000/year in children under
5 years) followed by S. sonnei (3.9/1000/year),
S. boydii (2.0/1000/year) and S. dysenteriae
(1.3/1000/year). The dominant S. ﬂexneri
Figure 3 Incidence of children under 5 years presenting
with dysentery in Karachi, Pakistan.
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During the study period 576 (7%) Campylobac-
er isolates were detected. The most frequently
solated Campylobacter species was C. jejuni
29/1000/year in children under 5 years) fol-
owed by Campylobacter coli (1.4/1000/year in
hildren under 5 years) and Campylobacter lar-
dis (0.3/1000/year in children under 5 years) (see
ig. 3).
There were signiﬁcant differences between
he presentation of Campylobacter infections and
higellosis. Shigellosis patients were signiﬁcantly
lder (mean age 6.3 years) compared to Campy-
obacter patients (mean age 2.8 years, p < 0.001;
able 2). As illustrated in Fig. 4a both shigellosis
nd Campylobacter infections peaked in the 2nd
ear of life and dropped below 10/1000/year by
he 5th year of life. In contrast to Campylobac-
er infection rates, shigellosis rates increased with
ncreasing age after age 30 (Fig. 4b).
Of the 10,540 enteric infections 1123 (11%) pre-
ented with dysentery. Out of which 123 (11%) were
higella species and 54 (5%) were Campylobac-
er species respectively. The dysentery incidence
as highest in S. ﬂexneri patients (3.5/1000/year
n children under 5 years) followed by C. jejuni
2.5/1000/year; Fig. 5).
C
ﬂ
t
s
apylobacter infected patients in Karachi, Pakistan.
Of 394 shigellosis patients 123 (31.2%) presented
ith dysentery in contrast only 54 (9.3%) of 576
atients with Campylobacter infections (Table 1).
he percentage of Campylobacter and shigellosis
atients presenting with dysentery varied with
he age of the patient and the infecting species
Fig. 5). Of 173 children with S. ﬂexneri infections
8 (34%) presented with dysentery in contrast to 31
f 69 (45%) adults (p = 0.05; Fig. 5). The percent-
ges of Campylobacter infected patients presenting
ith dysentery were identical to the percentages
atients presenting with dysentery from whom no
rganism could be isolated.
iscussion
urveillance in impoverished areas of Karachi found
elatively high shigellosis and even higher rates of
ampylobacter infection. Consistent with previous
tudies the dominant Campylobacter species was
. jejuni and the dominant Shigella species was S.
exneri [34]. The infection rates were highest in
he extremes of age. Both infections peaked in the
econd year of life. Newborns may be protected
gainst shigellosis and Campylobacter infection by
18 S.B. Sooﬁ et al.
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Figure 5 The percentage of patients with Shigella or Campylobacter infections presenting with dysentery (the 95%
conﬁdence intervals are shown as whiskers). *No organism isolated.
Table 1 Total population, number of cases over a 24months observation period, incidence rates and 95% conﬁdence
intervals in Karachi, Pakistan.
<60 months
n = 8381a
≥60 months
n = 51,203a
Total n = 59,584a
Cases IR/1000/year Cases IR/1000/year Cases IR/1000/year
Diarrhea 8174 488 (477—498) 2276 22 (21—24) 10,450 88 (86—90)
Dysentery 761 45 (41—50) 362 4 (3—4) 1123 9 (9—10)
Campylobacter infections 515 31 (27—35) 61 0.6 (0.4—0.9) 576 5 (4—5)
Shigellosis 292 17 (15—21) 102 1 (0.7—1.3) 394 3 (2.9—3.90)
Shigellosis dysentery 82 5 (4—7) 41 0.4 (0.2—0.6) 123 1.0 (0.8—1.3)
Campylobacter dysentery 45 3 (2—4) 9 0.1 (0.0—0.2) 54 0.5 (0.3—0.7)
a Denominator.
Table 2 Patient characteristics.
Shigellosis patients % Age Campylobacter patients % Age
na 372a 551b
Male 207 56% 320 58%
Age (mean) 6.3 — 2.8 —
Age (median) 2 — 1.5 —
Dysentery 119 32% 50 9%
Ever watery stools 236 63% 413 75%
Mucous stools 95 26% 125 23%
Abdominal pain 46 12% 43 8%
Rectal prolapse 1 0.3% 2 0.4%
Fever 135 36% 224 41%
Vomiting 46 12% 70 13%
Dehydration 17 5% 27 5%
Number of stools in the last 24 h
5 or less 139 37% 201 37%
6—10 118 32% 141 26%
11—30 10 3% 9 2%
Too many to count 105 28% 200 36%
a 22 patients with co-infections have been excluded.
b 25 patients with co-infections have.
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tcomparison of disease caused by Shigella and Cam
rans placental antibodies, breast milk, and per-
aps lower exposure rates [35—39]. Following a
eak in the ﬁrst years of life the rates for both infec-
ions dropped by more than an order of magnitude.
fter age 30 a trend for increasing shigellosis rates
as observed but not for Campylobacter. This ﬁnd-
ng may be explained by waning immunity against
higellosis with increasing age. There is no apparent
aning of immunity against Campylobacter infec-
ions.
Alternatively transmission of shigellosis may
ncrease with increasing age. Shigellosis is thought
o be mostly transmitted from person to person.
lies may in some places play a role in the trans-
ission of this disease [40]. The transmission of
ampylobacter is less well understood. It is thought
hat most poultry and many household pets are
ampylobacter carriers in Pakistan [41]. The age
istribution of C. jejuni infections is very different
n the USA where after a peak in the ﬁrst years of
ife a second peak of infections is observed during
he third decade of life [42]. Not surprisingly the
ge distribution of C. jejuni cases in Bangladesh
escribed by Glass and coworkers more than 20
ears ago was strikingly similar to our ﬁndings in
akistan [43].
Shigellosis and Campylobacter infections were
lso signiﬁcantly different in their presentation. A
igniﬁcantly larger proportion of shigellosis patients
resented with dysentery compared to patients
ith Campylobacter infections. Indeed the percent-
ge of Campylobacter infected patients presenting
ith dysentery was similar to the percentage in
atients from whom no organism could be iden-
iﬁed. It cannot be excluded that co-infection
ith agents responsible for the background rates
f dysentery also cause dysentery in Campylobac-
er infection patients. Older patients presented
ore frequently with dysentery compared to chil-
ren less than 5 years. This ﬁnding may be best
xplained by differences in health care utilization.
dult patients may only seek care for severe dis-
ase including dysentery. Children may be brought
o health care providers for more trivial disease
pisodes.
Two thirds of the shigellosis patients had at
ome stage of their diarrhea episode watery diar-
hea. The proportion of patients who had at
ome stage watery diarrhea was even higher in
atients with Campylobacter infections. An obser-
ation that challenges the notion which associates
higellosis exclusively with dysentery. Abdominal
ain was more frequently associated with shigel-
osis than with Campylobacter infections. While
higellosis appears to cause more pain and dysen-
ery. C. jejuni infections caused more frequent
a
P
s
tobacter species 19
owel movements. These ﬁndings are in agreement
ith ﬁndings from Bangladesh as well as other coun-
ries [42,43].
Shigellosis and Campylobacter infections appear
o have a similar seasonality. Consistent with
revious reports from Karachi, shigellosis and
ampylobacteriosis rates increased in the hot sum-
er months and dropped during the colder months
f the year [44]. The notion that ‘‘the seasonal vari-
tion of C. jejuni infection appears to be inﬂuenced
y rainfall’’ was not supported by our ﬁndings [45].
he increase in all enteric infections including C.
ejuni started well before the onset of rains in 2003
n Karachi.
Several hospital-based studies of enteric infec-
ions have been conducted in Pakistan including
arachi. The studies found that from between
% and 19% of stool specimens were Shigella
ositive [22—24,26,44]. In hospital based found
tudies Campylobacter was isolated from 17% to
5% of stool specimens [41,42,46—48]. In our study
higella species were isolated was from 5% of stool
pecimens that is at the lower end of the expected
ange. Campylobacter species were isolated from
% of specimens which is below the expected range.
Our study differs from previous reports in that
t was community-based and included patients of
ll ages hence patients with a potentially differ-
nt disease severity and prevalence. Furthermore
ur study was set up to detect shigellosis cases
nd methods were optimized to detect Shigella
pecies. Campylobacter unlike Shigella species are
ighly fastidious and may have escaped detection.
cohort study conducted in Mexico found that
hildren under 5 years had 2.1 episodes of Campy-
obacter infections per year [48]. In a hospital
ased study in the US Campylobacter spp. were
solated from 5% of stool specimens [42]. A study
n Bangladesh C. jejuni in 14% of outpatients pre-
enting with diarrhea to a research hospital [43].
owever C. jejuni was isolated less frequently from
illage children with diarrhea (5%).
The ﬁndings of our study were consistent with
nother done in Peru [49]. The Peruvian study
eveals that C. jejuni was the leading cause of diar-
hea and is more frequent in malnourished children
ith low socioeconomic background. The partici-
ants in our study also belonged to a low socio
conomic stratum of society. The Peruvian study
lso found an excess risk of GBS among Campylobac-
er enteritis patients [14]. We followed our cases
nd did not ﬁnd such trends.
Our study made use of passive surveillance.
atients were captured when they presented to
tudy clinics. This method has the advantage that
rivial diarrhea cases that usually would not seek
CF
R
[
[
[
[
[
[20
treatment are not included. Passive surveillance
however has the disadvantage that patients who
seek care outside the study clinics will escape the
surveillance. Furthermore 23% of diarrhea patients
who were captured by the surveillance did not
provide a stool specimen. For these reasons it
seems likely that our study underestimated the true
Shigellosis and Campylobacter infection rates.
Shigellosis and Campylobacter infection inci-
dence rates were highest in the second year of life.
Decreasing rates after the second year of life could
be due to acquired immunity. The trend for increas-
ing shigellosis rates in old age which was observed
for shigellosis but not for Campylobacter infections
could be due waning of immunity or differences in
exposure. Shigellosis presented signiﬁcantly more
often frequently with abdominal pain and dysen-
tery than Campylobacter infections indicating that
shigellosis may be a more severe illness and have
worse clinical consequences than Campylobacter
infections.
Conclusion
It is established that Campylobacteriosis and Shigel-
losis are the most common organisms causing
diarrhea. The shigellosis is comparatively a severe
form of enteric infection that needs instant atten-
tion. There has also been a perceptible increase
in ciproﬂoxacin resistance in our centre as also in
other parts of country, which could be attributed
to unrestricted administration of antibiotics for
diarrhea irrespective of aetiology. Many cases
the diarrhea are empirically treated with ﬂuo-
roquinolones particularly ciproﬂoxacin in general
practice clinics.
Due to increased disease burden, increased
symptom severity and proliferating drug resis-
tance both campylobacteriosis and shigellosis have
become signiﬁcant health problems; moreover they
are the diseases of poor and impoverished people
who do not have access to clean water and sani-
tary conditions, health care services and optimal
treatment. In the face of these facts it is empiri-
cally important to develop a low cost vaccine that
will protect the affected populations for a longer
duration. However the barrier to develop a vac-
cine against campylobacteriosis and shigellosis for
use in developing countries is the poor response
therefore further research studies of promising
campylobacteriosis and shigellosis vaccine candi-
dates are immediately desirable after conﬁrmation
of protection, immunogenicity, and safety in volun-
teer settings.
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